NO, nitrotyrosine, and cyclic GMP in signal transduction

Medical Science Monitor

Volumn 7, Issue 4, 2001, Pages 801-819

  Hanafy, Khalid A ^a   Krumenacker, Joshua S ^a   Murad, Ferid ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; CYCLIC GMP; GUANYLATE CYCLASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TYROSINE;

CELL COMMUNICATION; CHEMICAL REACTION; IMMUNOMODULATION; NITRATION; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; VASODILATATION;

NASA DISCIPLINE CARDIOPULMONARY; NON-NASA CENTER;

ANIMALS; CYCLIC GMP; HUMANS; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SIGNAL TRANSDUCTION; TYROSINE;

EID: 0034928756     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (203)

1. Cyclic GMP: Synthesis, metabolism, and function. Introduction and some historical comments
2. Regulation of cytosolic guanylyl cyclase by nitric oxide: The NO-cyclic GMP signal transduction system
3. The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication
4. Nitric oxide signaling: Would you believe that a simple free radical could be a second messenger, autacoid, paracrine substance, neurotransmitter, and hormone?
5. The 1996 Albert Lasker Medical Research Awards. Signal transduction using nitric oxide and cyclic guanosine monophosphate
6. Nitric oxide trapping of the tyrosyl radical of prostagtandin H synthase-2 leads to tyrosine iminoxyl radical and nitrotyrosine formation
7. Nitric oxide trapping of tyrosyl radicals generated during prostaglandin endoperoxide synthase turnover. Detection of the radical derivative of tyrosine 385
8. Inactivation of zinc finger transcription factors provides a mechanism for a gene regulatory role of nitric oxide
9. Cyclic guanosine monophosphate as a mediator of vasodilation
10. Regulation of cytosolic guanylyl cyclase by nitric oxide: The NO-cyclic GMP signal transduction system
11. The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication
12. Guanylyl cyclases and signaling by cyclic GMP
13. Autoxidation kinetics of aqueous nitric oxide
14. Nitric oxide-stimulated guanine nucleotide exchange on p21ras
15. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly
16. Interleukin 1beta decreases prostacyclin synthase activity in rȧt mesangial cells via endogenous peroxynitrite formation
17. Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries
18. Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats
19. ALS, SOD and peroxynitrite
20. Mammalian nitric oxide synthases
21. Cellular signaling with nitric oxide and cyclic guanosine monophosphate
22. S-Nitrosothiols: A class of nitric oxide-donor drugs
23. Regulation and subcellular location of nitrogen oxide synthases in RAW264. 7 Macrophages
24. Neuronal and endothelial nitric oxide synthase gene knockout mice
25. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase
26. Targeted disruption of the neuronal nitric oxide synthase gene
27. Impaired liver regeneration in inducible nitric oxide synthasedeficient mice
28. Hypertension in mice lacking the gene for endothelial nitric oxide synthase
29. Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3
30. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling
31. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice
32. Protein expression, vascular reactivity and soluble guanylate cyclase activity in mice lacking the endothelial cell nitric oxide synthase: Contributions of NOS isoforms to blood pressure and heart rate control
33. Elevated blood pressures in mice lacking endothelial nitric oxide synthase
34. Atherosclerosis, the road ahead
35. Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits
36. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment
37. Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion
38. Diffusion coefficients and half-lives of nitric oxide and N-nitroso-L-argininein rat cortex
39. Diffusion of nitric oxide
40. Oxidation of nitrogen oxides by bound dioxygen in hemoproteins
41. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells
42. Trapping of nitric oxide produced during denitrification by extracellular hemoglobin
43. 3rd. Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans
44. Nitrosative stress: Activation of the transcription factor OxyR
45. Redox sensing by prokaryotic transcription factors
46. Direct nitric oxide signal transduction via nitrosylation of iron-sulfur centers in the SoxR transcription activator
47. The aconitase family: Three structural variations on a common theme
48. Targeting mRNA to regulate iron and oxygen metabolism
49. Iron regulatory protein prevents binding of the 43S translation pre-initiation complex to ferritin and eALAS mRNAs
50. Evidence that the pathway of transferrin receptor mRNA degradation involves an endonucleolytic cleavage within the 3 UTR and does not involve poly(A) tail shortening
51. Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway
52. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages
53. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and 11-13
54. Nitric oxide signaling to iron-regulatory protein: Direct control of ferritin mRNA translation and transferrin receptor mRNA stability in transfected fibroblasts
55. Regulation of iron metabolism in murine J774 macrophages: Role of nitric oxide-dependent and -independent pathways following activation with gamma interferon and lipopolysaccharide
56. Effects of interferon-gamma and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2
57. Nitric oxide-mediated induction of ferritin synthesis in J774 macrophages by inflammatory cytokines: Role of selective iron regulatory protein-2 downregutation
58. Linkage of cell-mediated immunity to iron metabolism
59. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1
60. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducibte factor-1 activity by nitric oxide
61. Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling
62. Nitric oxide-inducible expression of heme oxygenase-1 in human cells. Translation-independent stabilization of the mRNA and evidence for direct action of nitric oxide
63. Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension
64. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases
65. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase
66. Studies of the primary oxygen intermediate in the reaction of fully reduced cytochrome oxidase
67. On the mechanism of inhibition of cytochrome c oxidase by nitric oxide
68. Inhibition of cytochrome c oxidase in turnover by nitric oxide: Mechanism and implications for control of respiration
69. Reversible binding and inhibition of catalase by nitric oxide
70. The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: A direct correlation between nitric oxide formation and protection
71. Nitric oxide and intracellular heme
72. The guanylyl cyclase family at y2k
73. The expanding family of guanylyl cyclases
74. Guanylyl cyclases, a growing family of signal-transducing enzymes
75. Mechanisms of regulation and functions of guanylyl cyclases
76. Sequence homologies between guanylyl cyclases and structural analogies to other signal-transducing proteins
77. Assignment of GUCIA2, the gene coding for the alpha 2 subunit of soluble guanylyl cyclase, to position 11q21-q22 on human chromosome 11
78. Molecular cloning and expression of cDNAs coding for soluble guanylate cyclases from rat lung
79. Molecular cloning of a cDNA coding for 70 kitodalton subunit of soluble guanylate cyclase from rat lung
80. Soluble guanylyl cyclase: Structure and regulation
81. Studying the structure and regulation of soluble guanylyl cyclase
82. Expression of nitric oxide-sensitive guanylyl cyclase subunits in human corpus cavernosum
83. Assignment of GUCY1B2, the gene coding for the beta2 subunit of human guanylyl cyclase to chromosomal band 13q14. 3 between markers D13S168 and D13S155
84. A variant of the alpha 2 subunit of soluble guanylyl cyclase contains an insert homologous to a region within adenylyl cyclases and functions as a dominant negative protein
85. Alternative splicing for the alpha 1 subunit of soluble guanylate cyclase
86. Heterogeneity in human soluble guanylate cyclase due to alternative splicing
87. A new form of guanylyl cyclase is preferentially expressed in rat kidney
88. The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action
89. Cloning of guanylyl cyclase isoforms
90. Expression of soluble guanylate cyclase activity requires both enzyme subunits
91. Soluble guanylate cyclase from bovine lung: Activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states
92. The ferrous heme of soluble guanylate cyclase: Formation of hexacoordinated complexes with carbon monoxide and nitrosomethane
93. Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method
94. Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion
95. Activation of purified soluble guanylate cyclase by protoporphyrin IX
96. Functional domains of soluble guanylyl cyclase
97. Functions of conserved cysteines of soluble guanylyl cyclase
98. Dominant negative mutants of nitric oxide-sensitive guanylyl cyclase
99. Exchange of substrate and inhibitor specificities between adenylyl and guanylyl cyclases
100. Molecular aspects of soluble guanylyl cyclase regulation
101. The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure
102. Cyclic GMP synthesis and function
103. Guanylyl cyclase, an enzyme catalyzing the formation of guanosine 3′, 5′-monophosphate from guanosine trihosphate
104. Appearance of magnesium guanylate cyclase activity in rat liver with sodium azide activation
105. Purification of guanylate cyclase from rat liver supernatant
106. Purification of soluble guanylate cyclase from rat lung
107. Particulate guanylate cyclase of skeletal muscle: Effects of Ca2 + and other divalent cations on enzyme activity
108. Purification of a soluble, sodium-nitroprusside-stimulated guanylate cyclases from bovine lung
109. Rat brain guanylate cyclase. Purification, amphiphilic properties and immunological characterization
110. Regulation of nitric oxide-responsive recombinant soluble guanylyl cyclase by calcium
111. The catalytic mechanism of mammalian adenylyl cyclase. Equilibrium binding and kinetic analysis of P-site inhibition
112. Estradiol rapidly inhibits soluble guanylyl cyclase expression in rat uterus
113. Rapid actions of plasma membrane estrogen receptors
114. Co-ordinated control of Endothelial NO synthase phosphorylation by PKC and PKA
115. Mechanism of YC-1-induced activation of soluble guanylyl cyclase
116. Characterization of 1H-[1, 2, 4]oxadiazolo [4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase
117. NO-independent regulatory site on soluble guanylate cyclase
118. Identification and characterization of a novel beta subunit of soluble guanylyl cyclase that is active in the absence of a second subunit and is relatively insensitive to nitric oxide
119. cDNA cloning and gene expression of human type Ialpha cGMP-dependent protein kinase
120. Distinct and specific functions of cGMP-dependent protein kinases
121. Defective smooth muscle regulation in cGMP kinase 1-deficient mice
122. Erectile dysfunction in cyclic GMP-dependent kinase 1-deficient mice
123. Effects of cyclic nucleotide dependent protein kinases on the endoplasmic reticulum Ca2+ pump of bovine pulmonary artery
124. Phosphorylation of the inositol 1, 4, 5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta
125. Cyclic guanosine monophosphate-dependent protein kinase is targeted to intermediate filaments and phosphorylates vimentin in A23187-stimulated human neutrophils
126. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function
127. Molecular identification of human G-substrate, a possible downstream component of the cGMP-dependent protein kinase cascade in cerebellar Purkinje cells
128. Mechanism of platelet inhibition by nitric oxide: In vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase
129. NO activation of fos promoter elements requires nuclear translocation of G-kinase I and CREB phosphorylation but is independent of MAP kinase activation
130. Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha
131. Molecular cloning, cDNA structure, and chromosomal localization of the human type II cGMP-dependent protein kinase
132. Cloning and expression of a novel cyclic GMP-dependent protein kinase from mouse brain
133. Cloning, expression, and in situ localization of rat intestinal cGMP-dependent protein kinase II
134. Guanosine 3′ 5′-cyclic monophosphate-dependent protein kinase II mediates heat-stable enterotoxin-provoked chloride secretion in rat intestine
135. Comparison of effects of uroguanylin, guanylin, and Escherichia coli heat-stable enterotoxin STa in mouse intestine and kidney: Evidence that uroguanylin is an intestinal natriuretic hormone
136. Natriuretic and kaliuretic activities of guanylin and uroguanylin in the isolated perfused rat kidney
137. Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II
138. Nitric oxide, donors, and inhibitors
139. Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats
140. Smooth muscle cell responsiveness to nitrovasodilators in hypertensive and normotensive rats
141. Structure and function of cyclic nucleotide-gated channels
142. Cyclic nucleotide-gated channels and calcium: An intimate relation
143. The renal cGMP-gated cation channel: Its molecular structure and physiological role
144. Taste buds have a cyclic nucleotide-activated channel, CNGgust
145. Selective loss of cone function in mice lacking the cyclic nucleotide-gated channel CNG3
146. Structure and function of çGMP-dependent protein kinases
147. The involvement of catalytic site thiol groups in the activation of soluble guanylate cyclase by sodium nitroprusside
148. Cyclic GMP and regulation of cyclic nucleotide hydrolysis
149. 2 solutions; the nature of the nitrosating intermediates
150. Nitric oxide and the regulation of gene expression
151. Redox reactivity of iron(III) porphyrins and heme proteins with nitric oxide. Nitrosyl transfer to carbon, oxygen, nitrogen, and sulfur
152. A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction
153. Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line
154. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation
155. Involvement of ras p21 in neurotrophin-induced response of sensory, but not sympathetic neurons
156. Effect of a dominant inhibitory Haras mutation on neuronal differentiation of PC12 cells
157. Activation of c-Ha-Ras by nitric oxide modulates survival responsiveness in neuronal PC12 cells
158. Fas-induced caspase denitrosylation
159. Nitric oxide inhibits Fas-induced apoptosis
160. Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation
161. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation
162. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain
163. Localization of nitric oxide synthase indicating a neural role for nitric oxide
164. Nitric oxide synthase activity endogenously modulates NMDA receptors
165. Excitatory amino acids as a final common pathway for neurologic disorders
166. The interaction of nitric oxide (NO) with the yeast transcription factor Ace1: A model system for NO-protein thiol interactions with implications to metal metabolism
167. Inhibition of NF-kappaB DNA binding by nitric oxide
168. Alteration of NF-kappa B p50 DNA binding kinetics by S-nitrosylation
169. Methylation-dependent gene silencing induced by interleukin 1 beta via nitric oxide production
170. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans
171. Amyotrophic lateral sclerosis, unfolding the toxicity of the misfolded
172. The reaction of no with superoxide
173. On the pH-dependent yield of hydroxyl radical products from peroxynitrite
174. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite
175. Inhibition of mitochondrial electron transport by peroxynitrite
176. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide
177. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not
178. Spin-trapping studies of peroxynitrite decomposition and of 3-morpholinosydnonimine N-ethylcarbamide auto oxidation: Direct evidence for metal-independent formation of free radical intermediates
179. Kinetics of superoxide dismutase and iron-catalyzed nitration of phenolics by peroxynitrite
180. Oxidative damage to extracellular fluids by ozone and possible protective effects of thiols
181. Spin trapping of nitrogen dioxide radical from photolytic decomposition of nitramines
182. Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide
183. Oxidative damage and tyrosine nitration from peroxynitrite
184. Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L
185. Interleukin 1beta decreases prostacyclin synthase activity in rat mesangial cells via endogenous peroxynitrite formation
186. Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries
187. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite
188. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts
189. The oxidative inactivation of sarcoplasmic reticulum Ca(2 C)-ATPase by peroxynitrite
190. Nitric oxide trapping of the tyrosyl radical of prostaglandin H synthase-2 leads to tyrosine iminoxyl radical and nitrotyrosine formation
191. Nitric oxide trapping of tyrosyl radicals generated during prostaglandin endoperoxide synthase turnover. Detection of the radical derivative of tyrosine 385
192. Nitric oxide donors activate the cyclo-oxygenase and peroxidase activities of prostaglandin H synthase
193. Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells
194. Inactivation of ribonucleotide reductase by nitric oxide
195. Quenching of the tyrosyl free radical of ribonucleotide Reductase by nitric oxide. Relationship to cytostasis induced in tumor cells by cytotoxic macrophages
196. Differential sensitivity of the tyrosyl radical of mouse Ribonucleotide reductase to nitric oxide and peroxynitrite
197. Nitration of succinyl CoA: 3-oxo acid CoA transferase in rats following endotoxin administration
198. An activity in rat tissues that modifies nitrotyrosine-containing proteins
199. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis
200. Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor
201. Peroxynitrite and atherosclerosis
202. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits
203. Motor neurons and neurofilaments in sickness and in health